1. Diferrante N, Nichols BL, Donnelly PV, et al. Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion. Proc Natl Acad Sci USA. 1971; 68:303-303.
2.
2. Dean MF, Stevens RL, Muir H, et al. A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses. J Inherited Metab Dis. 1983;6:62-62.
3.
3. Yeager AM, Singer HS, Buck JR, et al. A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases. Am J Med Genet. 1985;22:347-347.
4.
4. Parkman R.The application of bone marrow transplantation to the treatment of genetic diseases. Science. 1986;232:1373-1373.
5.
5. Barton NW, Brady RO, Dambrosia JM, et al. Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl JMed. 1991;324:1464-1464.
6.
6. Bembi B, Comelli M, Scaggiante B, et al. Treatment of sphingomyelinase deficiency by repeated implantations of amniotic epithelial cells. Am J Med Genet. 1992;44:527-527.
7.
7. Cerneca F, Andolina M, Simeone R, et al. Treatment of Patients with Niemann-Pick Type Is Using Repeated Amniotic Epithelial Cells Implantation: Corrections of Aggregation and Coagulation Abnormalities. Clin Pediatr. (this issue).
8.
8. Yeyati PL, Agmon V, Fillat C, et al. Fluorescence-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correction. Hum Gene Ther. 1995; 6:975-975.
